These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 17002794

  • 21. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM.
    Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
    [Abstract] [Full Text] [Related]

  • 22. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [Abstract] [Full Text] [Related]

  • 23. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
    Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R.
    Minerva Anestesiol; 2010 May; 76(5):325-33. PubMed ID: 20395894
    [Abstract] [Full Text] [Related]

  • 24. Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine With Morbidity and Mortality in Patients With Necrotizing Soft Tissue Infections.
    Hansen MB, Rasmussen LS, Garred P, Pilely K, Wahl AM, Perner A, Madsen MB, Hedegaard ER, Simonsen U, Hyldegaard O.
    Shock; 2018 Jun; 49(6):667-674. PubMed ID: 28863028
    [Abstract] [Full Text] [Related]

  • 25. Asymmetric dimethyl-arginine metabolism in a murine model of cigarette smoke-mediated lung inflammation.
    Staab EB, Weigel J, Xiao F, Madayiputhiya N, Wyatt TA, Wells SM.
    J Immunotoxicol; 2015 Jun; 12(3):273-82. PubMed ID: 25913572
    [Abstract] [Full Text] [Related]

  • 26. ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
    Tanhäuserová V, Tomandl J, Pácal L, Klepárník M, Malúšková D, Bartáková V, Kuricová K, Rehořová J, Stěpánková S, Svojanovský J, Olšovský J, Bělobrádková J, Krusová D, Jurajda M, Mužík J, Pavlík T, Kaňková K.
    Kidney Blood Press Res; 2012 Jun; 36(1):200-8. PubMed ID: 23147199
    [Abstract] [Full Text] [Related]

  • 27. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M, Liu L, Guo Z, Xiong Y.
    Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305
    [Abstract] [Full Text] [Related]

  • 28. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.
    Visser M, Vermeulen MA, Richir MC, Teerlink T, Houdijk AP, Kostense PJ, Wisselink W, de Mol BA, van Leeuwen PA, Oudemans-van Straaten HM.
    Br J Nutr; 2012 May 14; 107(10):1458-65. PubMed ID: 22129964
    [Abstract] [Full Text] [Related]

  • 29. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.
    Winkler MS, Nierhaus A, Rösler G, Lezius S, Harlandt O, Schwedhelm E, Böger RH, Kluge S.
    Crit Care; 2018 Sep 19; 22(1):216. PubMed ID: 30231905
    [Abstract] [Full Text] [Related]

  • 30. Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II.
    Chobanyan-Jürgens K, Fuchs AJ, Tsikas D, Kanzelmeyer N, Das AM, Illsinger S, Vaske B, Jordan J, Lücke T.
    Amino Acids; 2012 Aug 19; 43(2):805-11. PubMed ID: 22075968
    [Abstract] [Full Text] [Related]

  • 31. A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.
    Buijs N, Oosterink JE, Jessup M, Schierbeek H, Stolz DB, Houdijk AP, Geller DA, van Leeuwen PA.
    Angiogenesis; 2017 Nov 19; 20(4):557-565. PubMed ID: 28741166
    [Abstract] [Full Text] [Related]

  • 32. Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.
    Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2007 May 19; 18(5):1525-33. PubMed ID: 17409314
    [Abstract] [Full Text] [Related]

  • 33. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.
    Wang D, Gill PS, Chabrashvili T, Onozato ML, Raggio J, Mendonca M, Dennehy K, Li M, Modlinger P, Leiper J, Vallance P, Adler O, Leone A, Tojo A, Welch WJ, Wilcox CS.
    Circ Res; 2007 Sep 14; 101(6):627-35. PubMed ID: 17673667
    [Abstract] [Full Text] [Related]

  • 34. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.
    Transl Res; 2013 Aug 14; 162(2):67-76. PubMed ID: 23707198
    [Abstract] [Full Text] [Related]

  • 35. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.
    Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamada S, Shoji H, Takeuchi M, Ueda S, Matsui T, Adachi H, Okuda S, Yamagishi S.
    Pharmacol Res; 2009 Dec 14; 60(6):515-8. PubMed ID: 19450686
    [Abstract] [Full Text] [Related]

  • 36. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A, Zhao Y, Warren JS.
    Nephrol Dial Transplant; 2008 May 14; 23(5):1513-20. PubMed ID: 18204093
    [Abstract] [Full Text] [Related]

  • 37. Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes.
    Fogarty RD, Abhary S, Javadiyan S, Kasmeridis N, Petrovsky N, Whiting MJ, Craig JE, Burdon KP.
    J Diabetes Complications; 2012 May 14; 26(3):195-8. PubMed ID: 22521321
    [Abstract] [Full Text] [Related]

  • 38. DDAH gene and cardiovascular risk.
    Valkonen VP, Tuomainen TP, Laaksonen R.
    Vasc Med; 2005 Jul 14; 10 Suppl 1():S45-8. PubMed ID: 16444868
    [Abstract] [Full Text] [Related]

  • 39. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2006 Aug 14; 17(8):2176-83. PubMed ID: 16807406
    [Abstract] [Full Text] [Related]

  • 40. Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.
    Jacobi J, Maas R, Cardounel AJ, Arend M, Pope AJ, Cordasic N, Heusinger-Ribeiro J, Atzler D, Strobel J, Schwedhelm E, Böger RH, Hilgers KF.
    Am J Pathol; 2010 May 14; 176(5):2559-70. PubMed ID: 20348244
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.